20:56 , Jan 3, 2019 |  BC Innovations  |  Emerging Company Profile

Auransa’s AI-predicted pipeline

Auransa Inc. has built a predictive AI-based discovery engine that analyzes patient-derived data to identify and develop the right compound for each patient subpopulation in less time than traditional discovery methods. “The engine unbiasedly reveals...
16:09 , Apr 26, 2018 |  BC Innovations  |  Emerging Company Profile

Mammoth makes Dx CRISPR

Mammoth Biosciences emerged from stealth with an exclusive license to Jennifer Doudna’s CRISPR-based diagnostics technology, which could enable faster diagnosis of a range of diseases than PCR-based sequencing and culture-based techniques and be more adaptable...
19:05 , Oct 13, 2017 |  BioCentury  |  Finance

Repurposing Recursion

With a $60 million series B round and a fourth pharma partnership, Recursion Pharmaceuticals Inc. plans to expand the use of its phenotypic screening platform to a broader range of chemical libraries and therapeutic areas....
23:33 , Oct 10, 2017 |  BC Extra  |  Company News

Recursion, Takeda enter rare disease discovery partnership

Recursion Pharmaceuticals Inc. (Salt Lake City, Utah) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will collaborate to discover preclinical rare disease candidates for Takeda's TAK-celerator pipeline. Recursion will receive an undisclosed upfront payment and is eligible...
16:06 , Mar 16, 2017 |  BC Innovations  |  Emerging Company Profile

More needles, less haystack

Companies developing blood-based diagnostics for cancer inevitably grapple with the challenge of too little cancer-related genetic material in patient samples to make reliable diagnoses. Liquid biopsy newco Freenome Inc. is developing tests for early stage...
21:37 , Jan 6, 2017 |  BC Week In Review  |  Financial News

Synthego completes venture financing

Synthego raised $41 million in a series B round led by 8VC. New investors AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Real Estate Equities, ZhenFund and individual investors joined existing investors Founders Fund, Menlo...
00:09 , Jan 5, 2017 |  BC Extra  |  Financial News

CRISPR tools play Synthego raises $41M in series B

Synthetic RNA company Synthego Corp. (Redwood City, Calif.) raised $41 million in a series B round led by 8VC. New investors AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Real Estate Equities, ZhenFund, and University...
03:13 , Dec 1, 2016 |  BC Week In Review  |  Financial News

Transcriptic completes venture financing

Transcriptic raised $13.4 million in a series A-1 round led by Data Collective. New investors Digital Science and WuXi AppTec and existing investors, including AME Cloud Ventures, participated. Transcriptic Inc. , Menlo Park, Calif. ...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Financial News

Recursion Pharmaceuticals completes venture financing

Recursion Pharmaceuticals LLC , Salt Lake City, Utah   Business: Computational chemistry/biology, Neurology, Hematology   Date completed: 2016-10-03   Type: Venture financing   Raised: $12.9 million   Investors: Lux Capital; Obvious Ventures; Epic Ventures; Data...
07:00 , Oct 3, 2016 |  BC Extra  |  Financial News

Repurposing play Recursion raises $12.9M

Recursion Pharmaceuticals LLC (Salt Lake City, Utah) raised $12.9 million in a series A round led by Lux Capital. Obvious Ventures, Epic Ventures, Data Collective, AME Cloud Ventures, Wild Basin Investments, and angel investors also...